VANCOUVER, British Columbia, June 26, 2012 /PRNewswire-Asia/ -- Insiderslab.com has issued insider trading reports and Equity Research for the following companies: Arena Pharmaceuticals (NASDAQ:ARNA), Teva (NYSE:TEVA), Cemex (NYSE:CX), Occidental Petroleum (NYSE:OXY), Potash (NYSE:POT), and United States Steel (NYSE:X).
(Logo: http://photos.prnewswire.com/prnh/20100419/HKM001LOGO )
(Read full report by clicking the link below, you may need to copy and paste the full link to your browser.)
Report Highlights:
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA): In the last trading session, Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) slipped 6.93% to US$9.19, which was up 647.2% compared with the 52-week low and was 30.5% below the 52-week high. The move occurred on volume of 20 million shares, which is relative to 12 million shares traded on average each day. To obtain higher investment return, Insiderslab.com provides insider trading data to investors as Arena Pharmaceuticals, Inc. insiders like CEOs, CFOs, and Directors have a better understanding about the company's prospects. Check this insider trade report for ARNA here.
Read Full Report: http://www.insiderslab.com/PR3/062612B/ARNA/Arena.pdf
Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA): On June 21, Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) launched Olanzapine and Fluoxetine Capsules USP 6 mg/25 mg, 12 mg/25 mg, 6 mg/50 mg, and 12 mg/50 mg. This is Teva's generic equivalent of Symbyax® which was sold about US$82 million in the United States, citing IMS sales data. Teva Pharmaceutical shares advanced 4.50% to US$39.72. There were 13.99 million stock shares traded in the session, which was 2.5 times more than average volume. Since Teva insiders such as CEOs, CFOs and Directors have better access to company non-public information, Insiderslab.com thinks that investors would be wise to pay close attention to their stock trading behaviors. Check this insider trade report for TEVA here.
Read Full Report: http://www.insiderslab.com/PR3/062612B/TEVA/Teva.pdf
Cemex S.A.B de C.V. (ADR) (NYSE:CX): Cemex S.A.B de C.V. (ADR) (NYSE:CX) has a market capitalization of US$6.36 billion with price range within US$2.18 - US$8.46 over the past 52 weeks. In the last trading session, Cemex jumped US$0.41 per share (equivalent to 7.18%) to US$6.12, 181% above that low price. There were 22.24 million shares of Cemex exchanging hands as compared to its average daily volume of 11.51 million shares. Do you want to spend less time on picking stocks and raise your return at the same time? Want to trace the activities of Cemex insiders from now on?
Read Full Report: http://www.insiderslab.com/PR3/062612B/CX/Cemex.pdf
Today Insiderslab.com also observed abnormal trade volume for the following companies; insiders may involve trading in these companies. It will take some time for insiders to report their trades. Read these reports and add these companies into your Insider Trade Radar.
Occidental Petroleum Corporation (NYSE:OXY):
Read Full Report: http://www.insiderslab.com/PR3/062612B/OXY/OccidentalPetroleum.pdf
Potash Corporation /Saskatchewan (USA) (NYSE:POT):
Read Full Report: http://www.insiderslab.com/PR3/062612B/POT/Potash.pdf
United States Steel Corporation (NYSE:X):
Read Full Report: http://www.insiderslab.com/PR3/062612B/X/UnitedStatesSteel.pdf
Insider Filing Source Reference: All observations, analysis and reports are based on public information released by the U.S. Securities and Exchange Commission.
About Insiderslab.com:
Insiderslab.com covers insider trade data in major stock markets in the U.S., Hong Kong, Mainland China, and Singapore. Insiderslab.com features a team of experienced data analysts striving to provide the investment community with the tools, software, and data necessary to carry out more effective investment research.
Important Disclaimer:
Please visit insiderslab.com/disclaimers/disclaimers.php for details.
SOURCE Insiderslab.com; Insiders.hk
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article